ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
15 Oct 2020

Acarix byter Certified Advisor till Redeye

Pressmeddelande Malmö, Sverige, 15 oktober 2020 Acarix byter Certified Advisor till Redeye Acarix AB (publ) Acarix AB meddelar...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Oct 2020

Acarix changes Certified Advisor to Redeye

  Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB (publ) announces today that ...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Sep 2020

Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue

Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with the ove...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Sep 2020

Acarix genomför riktad nyemission av aktier till garanter i samband med den övertecknade företrädesemissionen

Pressmeddelande Malmö, Sverige, 29 september 2020 Acarix genomför riktad nyemission av aktier till garanter i samband med den överteck...
Continue reading
author-avatar acarix
Press
August 6, 2024
28 Sep 2020

Sista dag för handel med BTA

Pressmeddelande Malmö, Sverige, 28 september 2020 Sista dag för handel med BTA Sista dag för handel med Acarix AB:s (”Acarix” eller ”...
Continue reading
author-avatar acarix
Press
August 6, 2024
28 Sep 2020

Last day of trading in paid subscribed shares (Sw. BTA)

Press release Malmö, Sweden September 28, 2020 Last day of trading in paid subscribed shares (Sw. BTA) Last day of trading in subscri...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2020

Acarix announce final outcome in oversubscribed rights issue

Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB ("Acarix&...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2020

Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 11 september 2020 Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemissionAcarix AB (&#...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix offentliggör preliminärt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 9 september 2020 Acarix offentliggör preliminärt utfall i övertecknad företrädesemission INSIDERINFOR...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix announces preliminary outcome in oversubscribed rights issue

Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMATION:...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2020

Acarix offentliggör tilläggsprospekt

Press release Malmö, Sweden September 3, 2020 Acarix offentliggör tilläggsprospekt Styrelsen för Acarix AB ("Acarix" eller ...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Sep 2020

Acarix publishes a supplement to the prospectus

  Press releaseMalmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB (...
Continue reading
  • «
  • ‹
  • 23
  • 24
  • 25
  • 26
  • 27
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.